Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$43.2M |
| 2 |
Booking.com
BKNG
|
+$32.2M |
| 3 |
RTX Corp
RTX
|
+$32.1M |
| 4 |
Pfizer
PFE
|
+$30.2M |
| 5 |
Northrop Grumman
NOC
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.3M |
| 2 |
IBM
IBM
|
+$43.1M |
| 3 |
Lowe's Companies
LOW
|
+$36M |
| 4 |
Linde
LIN
|
+$29.1M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.23% |
| 2 | Technology | 15.76% |
| 3 | Healthcare | 12.99% |
| 4 | Consumer Discretionary | 12.18% |
| 5 | Consumer Staples | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Haemonetics
HAE
$4.95B
| $562K | 0.01% |
+4,889
| New | +$592K |
|
777
Shopify
SHOP
$192B
| $562K | 0.01% |
+14,140
| New | +$478K |
|
|
SEM
778
DELISTED
Select Medical
SEM
| $558K | 0.01% |
44,396
-27,713
| -38% | -$298K |
|
|
EXAS
779
DELISTED
Exact Sciences
EXAS
| $555K | 0.01% |
+6,005
| New | +$528K |
|
780
PayPal
PYPL
$52.7B
| $554K | 0.01% |
5,124
-181,550
| -97% | -$18.9M |
|
781
Applied Industrial Technologies
AIT
$12.5B
| $553K | 0.01% |
8,294
+535
| +7% | +$32.8K |
|
782
Insulet
PODD
$10.3B
| $553K | 0.01% |
3,231
+1,898
| +142% | +$316K |
|
783
Universal Electronics
UEIC
$62.5M
| $553K | 0.01% |
10,588
+2,588
| +32% | +$139K |
|
784
Malibu Boats
MBUU
$579M
| $549K | 0.01% |
13,417
-4,778
| -26% | -$173K |
|
|
PPL
785
PPL Corp
PPL
$25.9B
| $548K | 0.01% |
15,280
-12,600
| -45% | -$422K |
|
786
Black Hills Corp
BKH
$5.47B
| $546K | 0.01% |
6,947
-380
| -5% | -$29.3K |
|
787
Lennar Class A
LEN
$21B
| $545K | 0.01% |
10,085
-898
| -8% | -$51.2K |
|
788
Lamb Weston
LW
$7.38B
| $544K | 0.01% |
+6,319
| New | +$509K |
|
789
Buckle
BKE
$2.26B
| $542K | 0.01% |
20,055
-1,528
| -7% | -$36.3K |
|
790
GE Aerospace
GE
$361B
| $540K | 0.01% |
+9,709
| New | +$502K |
|
791
Amcor
AMCR
$22.5B
| $539K | 0.01% |
9,951
-765
| -7% | -$38.3K |
|
792
LendingTree
TREE
$433M
| $539K | 0.01% |
+1,776
| New | +$588K |
|
|
CCXI
793
DELISTED
ChemoCentryx, Inc.
CCXI
| $539K | 0.01% |
+13,636
| New | +$239K |
|
|
PVG
794
DELISTED
PRETIUM RESOURCES INC.
PVG
| $539K | 0.01% |
48,412
-4,459
| -8% | -$47.4K |
|
795
CoreCivic
CXW
$3.36B
| $535K | 0.01% |
+30,797
| New | +$488K |
|
796
Erie Indemnity
ERIE
$13.8B
| $534K | 0.01% |
+3,219
| New | +$568K |
|
797
Restaurant Brands International
QSR
$28.2B
| $531K | 0.01% |
8,325
+669
| +9% | +$44.8K |
|
|
SCHW
798
Charles Schwab
SCHW
$194B
| $524K | 0.01% |
11,028
+363
| +3% | +$16K |
|
799
Evercore
EVR
$11.2B
| $523K | 0.01% |
6,999
+2,524
| +56% | +$192K |
|
800
Nutrien
NTR
$35.9B
| $521K | 0.01% |
+10,875
| New | +$526K |
|
Similar funds
Joel Greenblatt's Q4 2019 Portfolio in Review
As of Q4 2019, Joel Greenblatt held 1,290 positions worth $5.45B, down 3.8% from $5.66B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Joel Greenblatt withdrew a net $632M in Q4 2019, closing 203 positions and reducing 508 holdings. Its most notable exit was Celgene Corp, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Phillips 66 worth $42.8M.
- Joel Greenblatt's largest Q4 2019 buy was Phillips 66: 384,100 shares worth $42.8M.
- Joel Greenblatt added most to Booking.com in Q4 2019, an estimated $32.2M increase.
- Joel Greenblatt's biggest Q4 2019 reduction was IBM, cutting an estimated $43.1M.
- Joel Greenblatt fully exited Celgene Corp in Q4 2019, selling an estimated $55.3M.
- Joel Greenblatt's ten largest holdings make up 11% of its $5.45B portfolio in Q4 2019.
- Joel Greenblatt opened 215 new positions and closed 203 in Q4 2019.
- Joel Greenblatt's portfolio value fell 3.8% quarter-over-quarter to $5.45B.
Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.